✦ LIBER ✦

Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer: Swedish Breast Cancer Cooperative Group J Natl Cancer Inst 1996:88:1543-49

Book ID: 117747602
Publisher: Elsevier Science
Year: 1997
Tongue: French
Weight: 224 KB
Volume: 1
Category: Article
ISSN: 1278-3218
DOI: 10.1016/s1278-3218(97)80010-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomised trial of two versus five year

Randomised trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer: preliminary results of the SITAM-01

✍ M. Sacco; M. Valentini; M. Belfiglio; A. Nicolucci; F. Pellegrini 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 141 KB

A Randomized Trial of Letrozole in Postm

A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer

✍ Goss, Paul E.; Ingle, James N.; Martino, Silvana; Robert, Nicholas J.; Muss, Hym 📂 Article 📅 2003 🏛 Massachusetts Medical Society 🌐 English ⚖ 219 KB

P101 Randomized trial of two versus four

P101 Randomized trial of two versus four years of adjuvant tamoxifen (AT) for postmenopausal women with node positive breast cancer

✍ M. Gallén; C. Alonso; B. Ojeda; P. Viladiu; M. Beltrán; J. Borras; A. Pelegri; I 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Five versus more than five years of tamo

Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors: Fisher B, Dignam J, Bryant J, DeCillis A, Wickeham L, Wolmark N, Constantino J, Redmond C, Fisher ER, Bowman DM, Deschênes L, Dimitrov NV, Margolese RG, Robidoux R, Shibata H, Terz A, Paterson AHG, Feldman MI, Farrar W, Evans J, Lickney HL J Natl Cancer Inst 1996:88:1529-42

📂 Article 📅 1997 🏛 Elsevier Science 🌐 French ⚖ 115 KB